QUALIBLOOD

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Transfert du si\u00E8ge social",
      "value": "Transfert du si\u00E8ge social",
      "object": null,
      "subject": "QUALIBLOOD"
    },
    {
      "type": "seat_change",
      "quote": "Par jugement du 11 mars 2026, le Tribunal de l\u0027entreprise de Li\u00E8ge - division Li\u00E8ge a homologu\u00E9 le transfert du si\u00E8ge de la soci\u00E9t\u00E9 QUALIBLOOD en liquidation au cabinet du liquidateur situ\u00E9 \u00E0 4000 Li\u00E8ge, rue Louvrex, 55/57.",
      "value": {
        "new_address": "4000 Li\u00E8ge, rue Louvrex, 55/57",
        "decision_date": "2026-03-11"
      },
      "object": null,
      "subject": "QUALIBLOOD"
    },
    {
      "type": "filing",
      "quote": "18 MARS 2026 BUNAL DE L\u0027ENTREPRISE DE LIE Greffe",
      "value": {
        "date": "2026-03-18",
        "court": "TRIBUNAL DE L\u0027ENTREPRISE DE LIEGE"
      },
      "object": null,
      "subject": "QUALIBLOOD"
    },
    {
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 01/04/2026 - Annexes du Moniteur belge",
      "value": {
        "date": "2026-04-01",
        "gazette": "Moniteur belge"
      },
      "object": null,
      "subject": "QUALIBLOOD"
    }
  ],
  "act_meta": {
    "model_id": 40,
    "extractor": "open-capture-27b-v3",
    "ocr_chars": 1022,
    "truncated": false,
    "needs_verify": true
  },
  "entities": [
    {
      "id": "QUALIBLOOD",
      "kbo": "0684.698.353",
      "kind": "company",
      "name": "QUALIBLOOD",
      "attrs": {
        "status": "en liquidation",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "Roman AYDOGDU",
      "kbo": null,
      "kind": "person",
      "name": "Roman AYDOGDU",
      "attrs": {
        "role": "liquidateur"
      }
    }
  ]
}

{
  "events": [
    {
      "date": "2025-10-28",
      "kind": "ontbinding",
      "liquidators": [
        {
          "name": "Ma\u00EEtre Roman AYDOGDU",
          "role": "vereffenaar"
        }
      ],
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E8cide que la soci\u00E9t\u00E9 anonyme \u00AB QUALIBLOOD \u00BB ... est dissoute et entre en liquidation \u00E0 dater de ce jour."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "final_status": "in_vereffening",
  "subject_company": {
    "kbo": "0684.698.353"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "MASEREEL Bernard",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-03-26",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de renouveler pour six ans, \u00E0 compter de ce jour (pour ce qui concerne les administrateurs d\u00E9j\u00E0 en fonction \u00E0 ce jour), et de d\u00E9signer comme administrateurs \u00E0 compter de ce jour, soit jusqu\u2019au 26 mars 2030: A/ Sur pr\u00E9sentation des actionnaires de classe A : 1. Monsieur MASEREEL Be"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DOUXFILS Jonathan",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "PHARMXPERTISE",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-03-26",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de renouveler pour six ans, \u00E0 compter de ce jour (pour ce qui concerne les administrateurs d\u00E9j\u00E0 en fonction \u00E0 ce jour), et de d\u00E9signer comme administrateurs \u00E0 compter de ce jour, soit jusqu\u2019au 26 mars 2030: A/ Sur pr\u00E9sentation des actionnaires de classe A : 2. La soci\u00E9t\u00E9 \u00E0 respons"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "LIEVENS Pierre-Yves",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0456316803",
        "name": "NAMUR INVEST",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-03-26",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de renouveler pour six ans, \u00E0 compter de ce jour (pour ce qui concerne les administrateurs d\u00E9j\u00E0 en fonction \u00E0 ce jour), et de d\u00E9signer comme administrateurs \u00E0 compter de ce jour, soit jusqu\u2019au 26 mars 2030: A/ Sur pr\u00E9sentation des actionnaires de classe A : 1. La soci\u00E9t\u00E9 anonyme \u00AB"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "SABATEL H\u00E9l\u00E8ne",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0808219836",
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-03-26",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de renouveler pour six ans, \u00E0 compter de ce jour (pour ce qui concerne les administrateurs d\u00E9j\u00E0 en fonction \u00E0 ce jour), et de d\u00E9signer comme administrateurs \u00E0 compter de ce jour, soit jusqu\u2019au 26 mars 2030: A/ Sur pr\u00E9sentation des actionnaires de classe A : 2. La soci\u00E9t\u00E9 \u00E0 respons"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "FOIDART Jean-Michel",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-03-26",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de renouveler pour six ans, \u00E0 compter de ce jour (pour ce qui concerne les administrateurs d\u00E9j\u00E0 en fonction \u00E0 ce jour), et de d\u00E9signer comme administrateurs \u00E0 compter de ce jour, soit jusqu\u2019au 26 mars 2030: A/ Sur pr\u00E9sentation des actionnaires de classe A : 3. Monsieur FOIDART Jea"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DELAUNOIS Philippe",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Conseils, Gestion, organisation",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-03-26",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de renouveler pour six ans, \u00E0 compter de ce jour (pour ce qui concerne les administrateurs d\u00E9j\u00E0 en fonction \u00E0 ce jour), et de d\u00E9signer comme administrateurs \u00E0 compter de ce jour, soit jusqu\u2019au 26 mars 2030: B/ Sur pr\u00E9sentation des actionnaires de classe B : La soci\u00E9t\u00E9 anonyme \u00AB Co"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DE SAINT-HUBERT Marie",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0641733885",
        "name": "Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth \u2013 UCL - Namur",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-03-26",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de renouveler pour six ans, \u00E0 compter de ce jour (pour ce qui concerne les administrateurs d\u00E9j\u00E0 en fonction \u00E0 ce jour), et de d\u00E9signer comme administrateurs \u00E0 compter de ce jour, soit jusqu\u2019au 26 mars 2030: C/ Sur pr\u00E9sentation des actionnaires de classe C : L\u2019association sans but "
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "WINAND Julie",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "WinAndGrow",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-04-01",
      "evidence_quote": "Le Conseil d\u0027administration d\u00E9signe comme d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re (Directrice g\u00E9n\u00E9rale, CEO) \u00E0 dater du 1 avril 2024 la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB WinAndGrow \u00BB dont le repr\u00E9sentant permanent est Madame Julie WINAND"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.698.353",
    "name_full": "QUALIBLOOD",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jonathan DOUXFILS",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-11-14",
      "evidence_quote": "En cons\u00E9quence, Messieurs Jonathan DOUXFILS, Jean-Michel FOIDART et Bernard MASEREEL sont nomm\u00E9s administrateurs de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Michel FOIDART",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-11-14",
      "evidence_quote": "En cons\u00E9quence, Messieurs Jonathan DOUXFILS, Jean-Michel FOIDART et Bernard MASEREEL sont nomm\u00E9s administrateurs de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Bernard MASEREEL",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-11-14",
      "evidence_quote": "En cons\u00E9quence, Messieurs Jonathan DOUXFILS, Jean-Michel FOIDART et Bernard MASEREEL sont nomm\u00E9s administrateurs de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Philippe DELAUNOIS",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-11-14",
      "evidence_quote": "En cons\u00E9quence, Monsieur Philippe DELAUNOIS, repr\u00E9sentant CGO SA, est nomm\u00E9 administrateur de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Pierre-Yves LIEVENS",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Namur Invest Preface",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-11-14",
      "evidence_quote": "En cons\u00E9quence, la soci\u00E9t\u00E9 anonyme \u003C NAMUR INVEST PREFACE \u003E avec pour repr\u00E9sentant permanent Monsieur Pierre-Yves LIEVENS et Madame Marie de SAINT-HUBERT, repr\u00E9sentante du CHU UCL Namur, sont nomm\u00E9s administrateurs de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Marie de SAINT-HUBERT",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-11-14",
      "evidence_quote": "En cons\u00E9quence, la soci\u00E9t\u00E9 anonyme \u003C NAMUR INVEST PREFACE \u003E avec pour repr\u00E9sentant permanent Monsieur Pierre-Yves LIEVENS et Madame Marie de SAINT-HUBERT, repr\u00E9sentante du CHU UCL Namur, sont nomm\u00E9s administrateurs de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.698.353",
    "name_full": "QUALIBLOOD",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Michel FOIDART",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "A l\u0027unanimit\u00E9 des membres pr\u00E9sents et repr\u00E9sent\u00E9s, l\u0027assemb\u00E9e approuve la nomination de Jean-Michel FOIDART comme administrateur jusqu\u0027au 14-11-2023."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.698.353",
    "name_full": "QUALIBLOOD",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": true,
    "object_change": false,
    "effective_date": "2020-12-08",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.698.353",
    "name_full": "QUALIBLOOD",
    "legal_form": "SA"
  },
  "signature_regime": "joint_by_class",
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "kind": "oprichting",
  "seat": "Namur, rue du S\u00E9minaire 20a",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1988-07-11",
        "name": "Jonathan DOUXFILS",
        "niss": null,
        "address": "Courri\u00E8re, rue des Grands Joncs, 27"
      },
      "share_class": "A",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 16000,
      "holder_person_name": "Jonathan DOUXFILS",
      "is_subscriber_only": false,
      "n_shares_subscribed": 1600,
      "amount_subscribed_eur": 16000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1988-12-07",
        "name": "Damien Claude GHELDOF",
        "niss": null,
        "address": "Floreffe/Floriffoux, rue Jules-Theunis, 3"
      },
      "share_class": "A",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 12000,
      "holder_person_name": "Damien Claude GHELDOF",
      "is_subscriber_only": false,
      "n_shares_subscribed": 1200,
      "amount_subscribed_eur": 12000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "BIOPHA"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "A",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "BIOPHA",
      "contribution_type": "cash",
      "amount_paid_in_eur": 6000,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 600,
      "amount_subscribed_eur": 6000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "CONSEILS, GESTION, ORGANISATION"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "B",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "CONSEILS, GESTION, ORGANISATION",
      "contribution_type": "cash",
      "amount_paid_in_eur": 10000,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 1000,
      "amount_subscribed_eur": 10000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "UNAMUR VENTURE"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "C",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "UNAMUR VENTURE",
      "contribution_type": "cash",
      "amount_paid_in_eur": 54000,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 5400,
      "amount_subscribed_eur": 54000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": "0641.733.885",
        "name": "Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth \u2013 UCL - Namur"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "C",
      "partner_role": null,
      "holder_org_kbo": "0641.733.885",
      "holder_org_name": "Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth \u2013 UCL - Namur",
      "contribution_type": "cash",
      "amount_paid_in_eur": 12000,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 1200,
      "amount_subscribed_eur": 12000,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 110000,
  "subject_company": {
    "kbo": "0684.698.353",
    "name_full": "QUALIBLOOD",
    "legal_form": "SNC"
  },
  "initial_directors": [],
  "incorporation_date": "2017-11-14",
  "post_incorporation_mandates": []
}